Abstract
In a multicenter study, the MICs of FK-037 for 90% of the strains tested (MIC90s) were < or = 1 microgram/ml for members of the family Enterobacteriaceae other than Citrobacter freundii, Enterobacter spp., and Serratia marcescens. Activity against Pseudomonas aeruginosa was variable, with a MIC50 and a MIC90 of 4 and 32 micrograms/ml, respectively. Relative to cefepime, however, FK-037 was less active against ceftazidime-resistant isolates of Enterobacter cloacae. The MIC90 of FK-037 for methicillin-resistant staphylococci was > 16 micrograms/ml.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fu K. P., Foleno B. D., Lafredo S. C., LoCoco J. M., Isaacson D. M. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1993 Feb;37(2):301–307. doi: 10.1128/aac.37.2.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fung-Tomc J., Dougherty T. J., DeOrio F. J., Simich-Jacobson V., Kessler R. E. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels. Antimicrob Agents Chemother. 1989 Apr;33(4):498–502. doi: 10.1128/aac.33.4.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Fuchs P. C. Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime. J Antimicrob Chemother. 1989 Jan;23(1):163–165. doi: 10.1093/jac/23.1.163. [DOI] [PubMed] [Google Scholar]
- Kato N., Kato H., Tanaka Y., Bando K., Watanabe K., Ueno K. In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria. Antimicrob Agents Chemother. 1993 May;37(5):957–961. doi: 10.1128/aac.37.5.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knapp C. C., Washington J. A. Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase. J Antimicrob Chemother. 1989 Dec;24(6):1011–1012. doi: 10.1093/jac/24.6.1011. [DOI] [PubMed] [Google Scholar]
- Neu H. C., Chin N. X., Huang H. B. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrob Agents Chemother. 1993 Mar;37(3):566–573. doi: 10.1128/aac.37.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]